Stefan Mutter

Dr. Stefan Mutter

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 October 2021 in Diabetologia
Verified
Journal Article
Open access
PDF file
SMStefan Mutter
Stefan Mutter
EVErkka Valo
Erkka Valo
VAViljami Aittomäki
Viljami Aittomäki
KNKristian Nybo
Kristian Nybo
LRLassi Raivonen
Lassi Raivonen
PGPer-Henrik Groop
Per-Henrik Groop
Aims/hypothesis: This prospective, observational study examines associations between 51 urinary metabolites and risk of progression of diabetic nephropathy in individuals with type 1 diabetes by employing an automated NMR metabolomics technique suitable for large-scale urine sample collections. Methods: We collected 24-h urine samples for 2670 individuals with type 1 diabetes from the Finnish Diabetic Nephropathy study and measured metabolite concentrations by NMR. Individuals were followed up for 9.0 ± 5.0 years until their first sign of progression of diabetic nephropathy, end-stage kidney disease or study end. Cox regressions were performed on the entire study population (overall progression), on 1999 individuals with normoalbuminuria and 347 individuals with macroalbuminuria at baseline. Results: Seven urinary metabolites were associated with overall progression after adjustment for baseline albuminuria and chronic kidney disease stage (p < 8 × 10−4): leucine (HR 1.47 [95% CI 1.30, 1.66] per 1-SD creatinine-scaled metabolite concentration), valine (1.38 [1.22, 1.56]), isoleucine (1.33 [1.18, 1.50]), pseudouridine (1.25 [1.11, 1.42]), threonine (1.27 [1.11, 1.46]) and citrate (0.84 [0.75, 0.93]). 2-Hydroxyisobutyrate was associated with overall progression (1.30 [1.16, 1.45]) and also progression from normoalbuminuria (1.56 [1.25, 1.95]). Six amino acids and pyroglutamate were associated with progression from macroalbuminuria. Conclusions/interpretation: Branched-chain amino acids and other urinary metabolites were associated with the progression of diabetic nephropathy on top of baseline albuminuria and chronic kidney disease. We found differences in associations for overall progression and progression from normo- and macroalbuminuria. These novel discoveries illustrate the utility of analysing urinary metabolites in entire population cohorts. Graphical

27 December 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
AAAila J. Ahola
Aila J. Ahola
SMStefan Mutter
Stefan Mutter
CFCarol Forsblom
Carol Forsblom
VHValma Harjutsalo
Valma Harjutsalo
PGPer-Henrik Groop
Per-Henrik Groop
We assessed meal timing, meal frequency, and breakfast consumption habits of adult individuals with type 1 diabetes (n = 1007) taking part in the Finnish Diabetic Nephropathy Study, and studied whether they are associated with glycaemic control. Data on dietary intake and blood glucose measurements were retrieved from food records. HbA1cwas measured at the study visit. In the whole sample, four peaks of energy intake emerged. Energy intake was the greatest in the evening, followed by midday. Altogether 7% of the participants reported no energy intake between 05:00 and 09:59 (breakfast skippers). While breakfast skippers reported lower number of meals, no difference was observed in the total energy intake between those eating and omitting breakfast. In a multivariable model, skipping breakfast was associated with higher mean blood glucose concentrations and lower odds of good glycaemic control. A median of 6 daily meals was reported. Adjusted for confounders, the number of meals was negatively associated with HbA1c, and the mean of the blood glucose measurements, but positively associated with the variability of these measurements. Our observations support the habit of a regular meal pattern, including consumption of breakfast and multiple smaller meals for good glycaemic control in adults with type 1 diabetes. However, an increase in the blood glucose variability may additionally be expected with an increase in the number of meals eaten.

26 June 2018 in International Journal of Epidemiology
Verified
Journal Article
Closed access
PDF file
SGSong Gao
Song Gao
SMStefan Mutter
Stefan Mutter
ACAaron Casey
Aaron Casey
VMVille-Petteri Mäkinen
Ville-Petteri Mäkinen
Large-scale epidemiological and population data provide opportunities to identify subgroups of people who are at risk of disease or exposed to adverse environments. Clustering algorithms are popular data-driven tools to identify these subgroups; however, relying exclusively on algorithms may not produce the best results if the dataset does not have a clustered structure. For this reason, we propose a framework (the R-library Numero) that combines the self-organizing map algorithm, permutation analysis for statistical evidence and a final expert-driven subgrouping step. We used Numero to define subgroups in two examples without an obvious clustering structure: a biomedical dataset of kidney disease and another dataset of community-level socioeconomic indicators. We benchmarked the Numero subgroupings against popular clustering algorithms (principal components, K-means and hierarchical clustering). The Numero subgroupings were more intuitive and easier to interpret without losing mathematical quality. Therefore, we expect Numero to be useful for exploratory analyses of population-based epidemiological datasets.

22 May 2020 in Diabetes Care
Verified
Journal Article
Closed access
PDF file
RLRaija Lithovius
Raija Lithovius
VHValma Harjutsalo
Valma Harjutsalo
SMStefan Mutter
Stefan Mutter
DGDaniel Gordin
Daniel Gordin
CFCarol Forsblom
Carol Forsblom
PGPer-Henrik Groop
Per-Henrik Groop
OBJECTIVE To estimate the risk of diabetic nephropathy (DN) progression, incident coronary heart disease (CHD) and stroke, and all-cause mortality associated with resistant hypertension (RH) in individuals with type 1 diabetes stratified by stages of DN, renal function, and sex. RESEARCH DESIGN AND METHODS This prospective study included a nationally representative cohort of individuals with type 1 diabetes from the Finnish Diabetic Nephropathy Study who had purchases of antihypertensive drugs at (±6 months) baseline visit (1995–2008). Individuals (N = 1,103) were divided into three groups: 1) RH, 2) uncontrolled blood pressure (BP) but no RH, and 3) controlled BP. DN progression, cardiovascular events, and deaths were identified from the individuals’ health care records and national registries until 31 December 2015. RESULTS At baseline, 18.7% of the participants had RH, while 23.4% had controlled BP. After full adjustments for clinical confounders, RH was associated with increased risk of DN progression (hazard ratio 1.95 [95% CI 1.37, 2.79], P = 0.0002), while no differences were observed in those with no RH (1.05 [0.76, 1.44], P = 0.8) compared with those who had controlled BP. The risk of incident CHD, incident stroke, and all-cause mortality was higher in individuals with RH compared with those who had controlled BP but not beyond albuminuria and reduced kidney function. Notably, in those with normo- and microalbuminuria, the risk of stroke remained higher in the RH compared with the controlled BP group (3.49 [81.20, 10.15], P = 0.02). CONCLUSIONS Our findings highlight the importance of identifying and providing diagnostic and therapeutic counseling to these very-high-risk individuals with RH.


2 January 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
EVErkka Valo
Erkka Valo
ARAnne Richmond
Anne Richmond
SMStefan Mutter
Stefan Mutter
EDEmma H. Dahlström
Emma H. Dahlström
ACArchie Campbell
Archie Campbell
NSNiina Sandholm
Niina Sandholm
Dissecting the genetic mechanisms underlying urinary metabolite concentrations can provide molecular insights into kidney function and open possibilities for causal assessment of urinary metabolites with risk factors and disease outcomes. Proton nuclear magnetic resonance metabolomics provides a high-throughput means for urinary metabolite profiling, as widely applied for blood biomarker studies. Here we report a genome-wide association study meta-analysed for 3 European cohorts comprising 8,011 individuals, covering both people with type 1 diabetes and general population settings. We identify 54 associations (p < 9.3 × 10−10) for 19 of 54 studied metabolite concentrations. Out of these, 33 were not reported previously for relevant urinary or blood metabolite traits. Subsequent two-sample Mendelian randomization analysis suggests that estimated glomerular filtration rate causally affects 13 urinary metabolite concentrations whereas urinary ethanolamine, an initial precursor for phosphatidylcholine and phosphatidylethanolamine, was associated with higher eGFR lending support for a potential protective role. Our study provides a catalogue of genetic associations for 53 metabolites, enabling further investigation on how urinary metabolites are linked to human health.